Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 +0.01 (+0.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Receivables - Other (2023 - 2026)

Updated

Telomir Pharmaceuticals' Receivables - Other was $526.00 in Q2 2026.

Analysis

Telomir Pharmaceuticals (TELO) Receivables - Other (2023 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Other at Telomir Pharmaceuticals came in at $318,234.

  • In earlier years, Receivables - Other was $130,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 526.00
Dec 31, 2025 318,234.00
Sep 30, 2024 130,000.00
Jun 30, 2024 130,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 130,000.00
API Access

Telomir Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TELO&period=max&api_key=YOUR_API_KEY